Research Topic · Peer-Reviewed

Cancer Biomarkers

Cancer biomarkers are measurable molecular indicators, found in tumor tissue, blood, urine, or other body fluids, whose presence, concentration, or alteration signals the existence, behavior, or treatment response of a malignancy. They encompass proteins, enzymes, hormones, metabolites, and nucleic acids such as cir…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 28× across the literature 🔖 ISSN 2572-3030 🗓 Reviewed July 2026

Overview

Cancer biomarkers are measurable molecular indicators, found in tumor tissue, blood, urine, or other body fluids, whose presence, concentration, or alteration signals the existence, behavior, or treatment response of a malignancy. They encompass proteins, enzymes, hormones, metabolites, and nucleic acids such as circulating microRNAs and DNA, and serve diagnostic, prognostic, predictive, and monitoring roles, supporting earlier detection, risk stratification, therapy selection, and surveillance for recurrence. Robust biomarkers require analytical validation and clinical qualification linking the marker to a defined outcome, and increasingly derive from immunoassays, immunohistochemistry, and high-throughput genomic and proteomic platforms. Research relevant to this area includes platform-based modeling for cancer biomarker development in drug discovery, epigenetic and long non-coding RNA biomarkers in head-and-neck cancer, dynamic plasma microRNA expression correlated with melanoma progression and PD-L1 status, immunogenomic approaches to immunomonitoring, oncofetal antigens, and trace-element profiles in thyroid nodules. The journal publishes peer-reviewed work in Cancer Genetics And Biomarkers spanning molecular, proteomic, and immunological marker discovery and validation, connecting laboratory characterization of tumor-associated molecules to clinical applications in diagnosis, prognosis, and the personalization of cancer therapy across diverse tumor types and biological platforms.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2018

Epigenetic Biomarkers in Head and Neck Cancer 

Gupta ShilpiCorresponding author
Stem Cell and Cancer Research Lab, Amity Institute of Molecular Medicine & Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Sector-125, Noida-201313, India.
Cancer Genetics And Biomarkers Cited by 11 doi:10.14302/issn.2572-3030.jcgb-18-2428
2018

Molecular Biomarkers: A Brief Review

Tarassishin LeonidCorresponding author
 Department of Biological Sciences.
Proteomics and Genomics Research doi:10.14302/issn.2326-0793.jpgr-18-2418
2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061

How this research is being cited

The 12 articles above have been cited 28 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Cancer Biomarkers, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Cancer Genetics And Biomarkers (ISSN 2572-3030).

Journal editorial board
Dr. Charlie Gourley · United Kingdom Dr. Xinyu Chen · United States Dr. Guru Prasad Maiti · United States

This page summarises published research for orientation; it is not medical or professional advice.